None among the four analysts who have coverage on IKS Health have a “buy” rating on the stock. Instead, all four of them have a “hold” rating.
Analysts do not see upside in this Jhunjhunwala-family backed stock despite sharp fall
Share it
Open an Account in less than 1 Min.
Need help? Call us
+919769768500
Services
Company
Get in touch
- +919769768500
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Marketrade Private Limited